Evaluating the Pieces in Big Pharma's Manufacturing Investments
The pharmaceutical majors target biologics and emerging markets in their manufacturing expansion activities and plans.

Advertisement: Get Your Equipment CLEANER, FASTER! Clean, rinse and dry your manufacturing equipment in minutes! Your cleaning process doesn’t have to be a hassle — get a more thorough cleaning in 3 easy steps. Learn More!

Report from India
Industry players brace themselves to face challenges as India's new drug-pricing policy kicks in full gear.

Advertisement: Nearly 100 global pharmas and consumer healthcare organizations partner with Ropack for contract manufacturing and packaging services. Focused on quality and reliability, Ropack provides bottling, blisters in multiple formats and pouch/sachet filling. Now Ropack also offers stick-pack filling of temperature- and humidity-sensitive products in a controlled environment.  Stick-pack, particularly for pediatric applications, is ideal for reformulation and patent protection. (513) 846-0921; paul.dupont@ropack.com Live Link: Ropack.com

True Pharma Innovation Lies in Quality, not Quantity, of Approvals, say FDA Analysts
Will FDA approvals this year will keep pace with last year’s near-record of 39 new molecular entities (NMEs) brought to market?

Advertisement: Support and Solutions from Agilent for Impurity Profiling: New Genotoxic Impurities Primer Agilent partners with Pharma for great results. Download or request a hard copy of our new guide, Genotoxic Impurities in Pharmaceutical Products:  Regulations and Analysis, authored by Ludwig Huber. The guide provides specific guidelines for genotoxic impurities and recommendations for implementation according to EMA and FDA guidelines. Get your copy now

Alice E. Till Selected AAPS President-Elect
Till, a PhRMA vice president, will lead AAPS starting in November; Executive Council and Section leadership positions were also announced.

Advertisement: Engineering Solutions to Solve Challenges in Pharmaceutical Processing: Powder Handling Live Webcast: Wednesday, September 11 at 11:00 am EDT. Register Free at www.pharmtech.com/solutions

FDA Reviews Outdated Guidance Documents
CDER withdraws some outdated guidance documents and makes plans to finalize others.

ViiV Healthcare Receives FDA Approval of HIV Drug Tivicay
ViiV Healthcare, a specialist HIV pharmaceutical company of GSK, Pfizer, and Shionogi gains approval for new HIV-1 treatment.

GSK Invests $50 million in Bioelectronic Medicines
The fund's first investment will be in SetPoint Medical, a California company.

ABPI Sets Guidelines on Clinical Trial Disclosure
ABPI toolkit provides guidance to pharmaceutical companies on how to meet clinical trial transparency requirements.

INTERPHEX and PDA Announce Sponsorship Agreement
INTERPHEX and the Parenteral Drug Association (PDA) announced a three-year sponsorship agreement, which aligns the objectives of both organizations to service key needs of the global pharmaceutical and biopharmaceutical industry.

Novartis Receives Third FDA Breakthrough Designation
FDA has granted Novartis breakthrough therapy designation to BYM338 for sporadic inclusion body myositis.

FDA and EMA Publish Assessment of QbD for Marketing Applications
Agencies collaborate to ensure consistent product quality.